Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


He, PA

Canzhong He, Emmaus, PA US

Patent application numberDescriptionPublished
20100061036INTERDIGITATED CAPACITORS - The specification describes matched capacitor pairs that employ interconnect metal in an interdigitated form, and are made with an area efficient configuration. In addition, structural variations between capacitors in the capacitor pair are minimized to provide optimum matching. According to the invention, the capacitor pairs are interdigitated in a manner that ensures that the plates of each pair occupy common area on the substrate. Structural anomalies due to process conditions are compensated in that a given anomaly affects both capacitors in the same way. Two of the capacitor plates, one in each pair, are formed of comb structures, with the fingers of the combs interdigitated. The other plates are formed using one or more plates interleaved between the interdigitated plates.03-11-2010

Ching He, Allison Park, PA US

Patent application numberDescriptionPublished
20090002868Read after write enhancement for bit patterned media - A read/write head for use with bit-patterned media detects write synchronization errors between a write clock and the bit-patterned media. In particular, the read/write head writes data to the bit-patterned media using a write clock. The data is then read from the bit-patterned media and used to detect write synchronization errors between the write clock and the location of bit-islands on the bit-patterned media. Based on detected write synchronization errors, the phase associated with the write clock is modified to align the write clock with the location of bit-islands on the bit-patterned media.01-01-2009
20090002896Magnetic writer for patterned media with increased write field - A magnetic writer writes to a magnetic medium including a plurality of tracks that each includes a plurality of isolated magnetic elements for storage of information. The magnetic writer includes a write element having a write element tip having a leading edge, a trailing edge, and first and second side edges extending between the leading edge and the trailing edge. A side shield is proximate the first side edge and no shield is proximate the second side edge.01-01-2009
20090003144Method and system for error checking in a bit-patterned media - A disc drive system provides increased reliability by detecting and correcting errors associated with bit-patterned media. Write synchronization errors associated with bit-patterned media are addressed by including data storage for temporarily storing data that is being written to the disc drive. The data is read from both the disc drive and the storage medium and compared to detect write synchronization errors. A disc drive system for correcting write synchronization errors includes an encoder, non-volatile storage, and decoder device for implementing a parity-based scheme for increased reliability. Data strings being written to the disc drive are combined in an encoder to generate a parity string. The address of the data being written to the disc drive, along with the updated parity string is stored to the non-volatile storage. The data strings are read from the disc drive by the decoder. If uncorrectable errors are identified, the decoder employs the parity string in conjunction with the other data strings written to the disc drive to reconstruct the data string with uncorrectable errors.01-01-2009
20100020429Converting Timing Errors Into Symbol Errors to Handle Write Mis-Synchronization in Bit-Patterned Media Recording Systems - A method includes: writing data to a bit-patterned media at times determined by a clock having a period that is offset from a bit island period by a fixed offset to create one insertion or one deletion approximately within a predetermined number of bit islands, reading the data, and correcting the read data using error correction. An apparatus that implements the method is also provided.01-28-2010
20110096430Converting Timing Errors into Symbol Errors to Handle Write Mis-Synchronization in Bit-Patterned Media Recording Systems - A method includes writing data to a bit-patterned media at times determined by a clock having a period that is offset from a bit island period by a fixed offset to create one insertion or one deletion approximately within a predetermined number of bit islands, reading the data, and correcting the read data using error correction. An apparatus that implements the method is also provided.04-28-2011
20110249355METHOD AND SYSTEM FOR ERROR CHECKING IN BIT-PATTERNED MEDIA - A disc drive system provides increased reliability by detecting and correcting errors associated with bit-patterned media. Write synchronization errors associated with bit-patterned media are addressed by including data storage for temporarily storing data that is being written to the disc drive. The data is read from both the disc drive and the storage medium and compared to detect write synchronization errors. The disc drive system utilizes the identified write synchronization errors for at least one of timing recovery, equalizer training detection, error correction code application, and error recovery.10-13-2011

Patent applications by Ching He, Allison Park, PA US

Chunhong He, Boothwyn, PA US

Patent application numberDescriptionPublished
20080255154Amido Compounds And Their Use As Pharmaceuticals - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.10-16-2008
20090291946LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.11-26-2009
20090298808INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.12-03-2009
20110136781IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS - The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.06-09-2011
20120015928Amido Compounds And Their Use As Pharmaceuticals - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.01-19-2012
20120122858LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.05-17-2012
20120165305SUBSTITUTED IMIDAZOPYRIDAZINES AND BENZIMIDAZOLES AS INHIBITORS OF FGFR3 - The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases.06-28-2012

Patent applications by Chunhong He, Boothwyn, PA US

Chunhong He, Chadds Ford, PA US

Patent application numberDescriptionPublished
20110212967IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS - The present invention relates to imidazo[1,2-b][1,2,4]triazines that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer.09-01-2011

Fenjin He, Philadelphia, PA US

Patent application numberDescriptionPublished
20090142449Tofu production method - The tofu production method is a process for producing tofu that uses transglutaminase enzyme to improve the texture and elasticity of the tofu, so that soft or silken tofu is more resistant to mechanical abuse during food preparation, and firm tofu can be sliced. The amount of transglutaminase is less than 0.001 parts by weight, or less than 2 units per gram. According to one process, the coagulant and the transglutaminase are added to cold soymilk, placed into a tofu tray and sealed, heat-treated at 50° C. for 0.5-1 hour, then at 85° C. for 40-70 minutes to produce silken tofu. According to another process, the coagulant is added to the soymilk and the mixture is coagulated to form curds at 85° C., the whey is drained from the curds, the curds are cooled to 50° C., the transglutaminase is added, and the curds are placed into a pressing mold to make firm tofu.06-04-2009

Hongxian He, Drexel Hill, PA US

Patent application numberDescriptionPublished
20090176003MUTANT DELTA-8 DESATURASE GENES ENGINEERED BY TARGETED MUTAGENSIS AND THEIR USE IN MAKING POLYUNSATURATED FATTY ACIDS - The present invention relates to mutant delta-8 desaturase genes, which have the ability to convert eicosadienoic acid [20:2 omega-6, EDA] to dihomo-γ-linolenic acid [20:3, DGLA] and/or eicosatrienoic acid [20:3 omega-3, ETrA] to eicosatetraenoic acid [20:3 omega-3, ETA]. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-8 desaturase along with methods of making long-chain polyunsaturated fatty acids (PUFAs) using these mutant delta-8 desaturases in plants and oleaginous yeast are disclosed.07-09-2009
20110268864Mutant Delta-8 Desaturase Genes Engineered By Targeted Mutagensis and Their Use In Making Polyunsaturated Fatty Acids - The present invention relates to mutant delta-8 desaturase genes, which have the ability to convert eicosadienoic acid [20:2 omega-6, EDA] to dihomo-γ-linolenic acid [20:3, DGLA] and/or eicosatrienoic acid [20:3 omega-3, ETrA] to eicosatetraenoic acid [20:3 omega-3, ETA]. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-8 desaturase along with methods of making long-chain polyunsaturated fatty acids (PUFAs) using these mutant delta-8 desaturases in plants and oleaginous yeast are disclosed.11-03-2011

Patent applications by Hongxian He, Drexel Hill, PA US

Linli He, West Chester, PA US

Patent application numberDescriptionPublished
20090247754METHOD OF PREPARING HUPERZINE A AND DERIVATIVES THEREOF - The present invention is related to the synthesis of huperzine A. The synthesis includes a variety of process steps that increase productivity, reduce safety concerns, and allow for increasing production of compounds of desired optical isomer. The inventive methods may encompass a single improved reaction step that may be incorporated into a known reaction process for synthesizing huperzine A or a derivative thereof to improve the overall reaction. The inventive methods also encompass complete synthesis methods for preparing huperzine A or a derivative thereof.10-01-2009
20120214998Novel forms of a multicyclic compound - The present invention provides alternative forms of Compound I,08-23-2012

Liqi He, Furlong, PA US

Patent application numberDescriptionPublished
20100029649PHENYL-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL AS KINASE INHIBITORS - Compounds having the formula (I),02-04-2010
20100113458IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS - The invention provides compounds of Formula (I)05-06-2010
20120283241IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS - The invention provides compounds of Formula (I)11-08-2012
20130023514SUBSTITUTED PYRROLOTRIAZINES AS PROTEIN KINASE INHIBITORS - The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) pyrrolotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.01-24-2013

Patent applications by Liqi He, Furlong, PA US

Lizhen He, Allentown, PA US

Patent application numberDescriptionPublished
20090175880ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antib07-09-2009
20090324622ANTIBODY VACCINE CONJUGATES AND USES THEREFOR - The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (βhCG) antigen linked to an anti-mannose receptor (MR) antibody.12-31-2009
20100098704Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.04-22-2010
20100303816ANTIBODIES AGAINST HUMAN MELANOMA-ASSOCIATED CHONDROITIN SULPHATE PROTEOGLYCAN (MCSP) - The present invention provides isolated antibodies (e.g., humanized or human antibodies) that bind to the membrane-proximal domain (MP) of human Melanoma-Associated Chondroitin Sulphate Proteoglycan (MCSP), and are capable of mediating cytolysis of a cell expressing MCSP in the presence of human effector cells or complement. Methods of using such antibodies to induce cytolysis (e.g., ADCC or CDCC) of cells expressing MP-MCSP are also provided.12-02-2010
20110274685ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF - Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.11-10-2011
20120213771ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF - Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.08-23-2012
20120309031ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antib12-06-2012

Patent applications by Lizhen He, Allentown, PA US

Meng He, Murrysville, PA US

Patent application numberDescriptionPublished
20090146104ALIGNMENT FACILITIES FOR OPTICAL DYES - Various non-limiting embodiments disclosed herein provide phase-separating polymer systems including a cured polymeric liquid crystal matrix phase and a guest phase including at least one photoactive material where the guest phase separates from the matrix phase during the curing process. Optical elements, including ophthalmic elements and other articles of manufacture including the phase-separating polymer systems are also disclosed. Methods of forming a liquid crystal phase-separating photoactive polymer system are also described.06-11-2009
20090309076PHOTOCHROMIC COMPOUNDS - A photochromic compound is provided, which may be a pyran, an oxazine, or a fulgide. The photochromic compound has at least one substituent Q attached thereto, each Q independently being —N12-17-2009
20090323011MESOGEN CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed.12-31-2009
20090323012LIQUID CRYSTAL COMPOSITIONS COMPRISING MESOGEN CONTAINING COMPOUNDS - Liquid crystal compositions comprising compounds including at least one mesogenic substructure and at least one long flexible segment and a compound selected from a photochromic compound, a dichroic compound and a photochromic-dichroic compound and methods of synthesizing the same and their use in articles of manufacture and ophthalmic devices are disclosed.12-31-2009
20090326186MESOGEN CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed.12-31-2009
20100014010FORMULATIONS COMPRISING MESOGEN CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed.01-21-2010
20110128457ALIGNMENT FACILITIES FOR OPTICAL DYES - Provided are phase-separating polymer systems including a cured polymeric liquid crystal matrix phase and a guest phase including at least one photoactive material where the guest phase separates from the matrix phase during the curing process. Optical elements, including ophthalmic elements and other articles of manufacture including the phase-separating polymer systems are also disclosed. Methods of forming a liquid crystal phase-separating photoactive polymer system are also described.06-02-2011
20110129678Photochromic compounds and compositions - Described herein are compounds generally comprising an indeno[2′,3′:3,4]naptho[1,2-b]pyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles. Also described herein are methods for preparing certain photochromic compounds, compositions, and articles.06-02-2011
20110140056Indeno-fused ring compounds - The present invention relates to compounds represented by the following Formulas (I) and (II),06-16-2011
20110143141Photochromic compounds and compositions - The present invention relates to compounds represented by the following Formula I,06-16-2011
20110216273MESOGEN-CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen-containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed.09-08-2011
20120002141MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula Ia,01-05-2012
20120003401MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula I,01-05-2012
20120021144MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula I,01-26-2012
20120027960MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula Ic,02-02-2012
20120126185INDENO-FUSED RING COMPOUNDS - The present invention relates to compounds represented by the following Formulas (I) and (II),05-24-2012
20120156508PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS - Described herein are compounds generally comprising an indeno[2′,3′:3,4]naptho[1,2-b]pyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles.06-21-2012
20120156521PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS - Described herein are compounds generally comprising an indeno[2′,3′:3,4]naptho[1,2-b]pyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles. Also described herein are methods for preparing certain photochromic compounds, compositions, and articles.06-21-2012
20120157677LACTONE COMPOUNDS AND MATERIALS MADE THEREFROM - The present invention relates to lactone compounds represented by the following Formulas I and II, and methods of making such lactone compounds.06-21-2012
20120157678METHODS OF MAKING FUSED RING COMPOUNDS - The present invention relates to methods of making fused ring compounds, such as indeno-fused naphthols, and fused ring indenopyran compounds, such as indeno-fused naphthopyrans, that each employ an unsaturated compound represented by the following Formula II.06-21-2012
20120200907PHOTOCHROMIC COMPOUNDS - A photochromic compound is provided, which may be a pyran, an oxazine, or a fulgide. The photochromic compound has at least one substituent Q attached thereto, each Q independently being —N08-09-2012

Patent applications by Meng He, Murrysville, PA US

Qiuhong He, Wexford, PA US

Patent application numberDescriptionPublished
20090118611COILS FOR MAGNETIC RESONANCE SPECTROSCOPY AND IMAGING OF HUMAN BREAST - System(s) and method(s) for magnetic resonance imaging and spectroscopy, and magnetic resonance spectroscopic imaging (MRSI) are provided. A unified heteronuclear coil system includes a volume coil tuned to detect a first nuclei and a butterfly coil tuned to detect a second nuclei for simultaneous detection of both the first nuclei and the second nuclei signals from human breast tissue and perform MRIS. First nuclei and second nuclei each include 05-07-2009
20120274323MSC-SELMQC METHOD FOR SIMULTANEOUS MAPPING OF POLYUNSATURATED FATTY ACIDS, LACTATE AND CHOLINE IN HIGH FAT TISSUES - Systems and methods employing spin editing techniques to improve magnetic resonance spectroscopy (MRS) and magnetic resonance spectroscopic imaging (MRSI) are discussed. Using these spin editing techniques, magnetic resonance signals of one or more unwanted chemicals (that is, chemicals whose signals are to be filtered out or suppressed) chemicals can be suppressed, so that the signal(s) of a first set of chemicals can be obtained without signals from the one or more unwanted chemicals. Information about and differences between the molecular topologies of the first set of chemicals and the one or more unwanted chemicals can be used to design a sequence that suppresses the one or more unwanted chemicals while allowing acquisition of signal(s) from the first set of chemicals.11-01-2012

Shu He, Allentown, PA US

Patent application numberDescriptionPublished
20080275221Busulfan Immunoassay - Novel conjugates of busulfan and novel busulfan immunogens derived from α-substituted derivatives of busulfan and antibodies generated by these busulfan linked immunogens are useful in immunoassays for the quantification and monitoring of busulfan in biological fluids.11-06-2008
20090215078Doxorubicin Immunoassay - Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.08-27-2009
20120015385DOXORUBICIN IMMUNOASSAY - Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.01-19-2012
20120214184DOXORUBICIN IMMUNOASSAY - Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.08-23-2012

Patent applications by Shu He, Allentown, PA US

Shun He, Allentown, PA US

Patent application numberDescriptionPublished
20090215082Doxorubicin Immunoassay - Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.08-27-2009

Xiaofeng He, Aston, PA US

Patent application numberDescriptionPublished
20090132347Systems And Methods For Aggregating And Utilizing Retail Transaction Records At The Customer Level - A method and system is provided for storing and manipulating customer purchase information received from a plurality of sources. A computer system may be used comprising a storage device for storing the customer purchase information and a processor for processing the customer purchase information. The method may include receiving the customer purchase information; organizing the customer purchase information within a predetermined organizational structure; creating a customer preference based at least in part on the customer purchase information; and aggregating customer purchases for merchant classes based on the customer purchase information so as to generate aggregated customer purchase information. The method may further include generating marketing information based on at least one of the customer preference and the aggregated customer purchase information.05-21-2009

Xiaoyi He, Orefield, PA US

Patent application numberDescriptionPublished
20100038593Tubular Reactor With Jet Impingement Heat Transfer - A tubular reactor and method for producing a product mixture in a tubular reactor where the tubular reactor comprises an internal catalytic insert having orifices for forming fluid jets for impinging the fluid on the tube wall. Jet impingement is used to improve heat transfer between the fluid in the tube and the tube wall in a non-adiabatic reactor. The tubular reactor and method may be used for endothermic reactions such as steam methane reforming and for exothermic reactions such as methanation.02-18-2010
20100077944COMBUSTION SYSTEM WITH PRECOMBUSTOR - A precombustor having a chamber having a first end and a second end, and an inlet configured to deliver a substantially parallel flow of solid fuel surrounded by oxygen at the first end. The first end further includes a recirculation step and the second end fluidly communicates with a furnace. The inlet and the recirculation step are arranged to form a recirculation zone of at least a portion of the solid fuel and the oxygen. A combustion system and method for operating a combustion system are also disclosed.04-01-2010
20100077968OXY/FUEL COMBUSTION SYSTEM HAVING COMBINED CONVECTIVE SECTION AND RADIANT SECTION - A heat transfer system having a a radiant source, a first heat exchanger configured to permit a first fluid to flow therethrough, and a thermal shield configured to provide controlled radiative heat from the radiant source to the first exchanger. The radiant source is a flame. The thermal shield is a second heat exchanger configured to permit a second fluid to flow therethrough or a non-contact thermal shield fabricated from a material arranged to provide controlled radiative heat exposure from the radiant source to the first exchanger. Oxy/coal combustion systems are also disclosed.04-01-2010
20100081098Combustion System with Precombustor for Recycled Flue Gas - A precombustor system to be used in conjunction with an oxy-fuel burner employing recycled flue gas is disclosed. A method of introducing streams into the precombustor to achieve desired improvements in flame properties is also disclosed.04-01-2010
20100313604Furnace and Process for Controlling the Oxidative State of Molten Materials - A method useful with oxy-fuel combustion and in a furnace which contains molten material, wherein either substoichiometric or superstoichiometric combustion and low velocity injection of fuel and primary and secondary oxidant in an oxy-fuel burner are carried out in an orientation which forms either a reducing or oxidizing atmosphere proximate the molten surface.12-16-2010
20110154950Burner and Method for Processing Oxidizable Materials - Burner assembly for use in industrial heating and melting applications of material susceptible to oxidation at elevated temperatures is comprised of a flow passage of oxidant surrounded by an annular flow passage of fuel whereby the oxidant is substantially contained inside the fuel layer up to at least 5 oxidant nozzle diameters downstream of the burner outlet in order to minimize contact between the oxidant and the furnace load.06-30-2011
20110194991Tubular Reactor With Jet Impingement Heat Transfer - A tubular reactor for producing a product mixture in a tubular reactor where the tubular reactor comprises an internal catalytic insert with cup-shaped structures having orifices for forming fluid jets for impinging the fluid on the tube wall. Jet impingement is used to improve heat transfer between the fluid in the tube and the tube wall in a non-adiabatic reactor. The tubular reactor and method may be used for endothermic reactions such as steam methane reforming and for exothermic reactions such as methanation.08-11-2011
20110200955Liquid Fuel Combustion Process and Apparatus - An apparatus for combustion of a liquid fuel, such as an atomizer or burner, and an associated method using the apparatus for combusting an atomized liquid fuel. The apparatus for combustion has in outer conduit, an inner conduit and a spray tip. The spray tip has a mixing chamber for receiving a liquid fuel and an atomizing gas, and an orifice for discharging the liquid fuel and atomizing gas mixture as an atomized liquid fuel. The inner conduit has external fins where at least some of the external fins contact the inner surface of the spray tip.08-18-2011
20120055592Method of Metal Processing Using Cryogenic Cooling - Described herein are a method, an apparatus, and a system for metal processing that improves one or more properties of a sintered metal part by controlling the process conditions of the cooling zone of a continuous furnace using one or more cryogenic fluids. In one aspect, there is provided a method comprising: providing a furnace wherein the metal part is passed therethough on a conveyor belt and comprises a hot zone and a cooling zone wherein the cooling zone has a first temperature; and introducing a cryogenic fluid into the cooling zone where the cryogenic fluid reduces the temperature of the cooling zone to a second temperature, wherein at least a portion of the cryogenic fluid provides a vapor within the cooling zone and cools the metal parts passing therethrough at an accelerated cooling rate.03-08-2012
20120122047Selective Adjustment of Heat Flux for Increased Uniformity of Heating a Charge Material in a Tilt Rotary Furnace - A method of heating a charge material by controlling heat flux in a tilt rotary furnace is disclosed. Combustion by the burner forms a heat release profile including a high heat flux region. The positioning of the high heat flux region is controllable by providing a controlled amount of secondary or staged oxidant. The burner is configured and controlled to position a region of high heat flux at a position corresponding to an area requiring greater heating, such as the area of maximum charge depth in the furnace to provide substantially uniform melting and heat distribution.05-17-2012
20120292833Heating Method and System for Controlling Air Ingress into Enclosed Spaces - A heating method for heating vessels, the vessels having enclosed spaces therein and controlling air ingress into the enclosed spaces through gaps. The method includes providing a lid structure for the vessel having the enclosed space, the lid structure having a burner assembly mounted therein. The burner is configured to provide a predetermined flame diameter. The vessel and lid structure are mated such that the gap is formed between the vessel and the lid structure. Fuel and oxidant are discharged from the burner assembly under conditions to provide the predetermined flame diameter and impart a flame velocity sufficiently large to create an outward gas flow from the enclosed space through the gap and control air ingress.11-22-2012

Patent applications by Xiaoyi He, Orefield, PA US

Yiping He, Phildephia, PA US

Patent application numberDescriptionPublished
20110014214Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers - Provided are methods for the diagnosis and treatment of acute myelogenous leukemia. In particular, the present invention relates to the use of Trib2 polynucleotides and polypeptides for the diagnosis and treatment of acute myelogenous leukemia (AML) by assessing myeloid cells of a patient, or malignancies associated with Trib2, C/EBPαp30 or C/EBPαp42, such as AML or lung cancer, by assessing hematopoietic stem cells of the patient.01-20-2011

Yuhong He, Honey Brook, PA US

Patent application numberDescriptionPublished
20130090444POLAR, MULTI-HYDROXYL FUNCTIONAL AMINO COMPOUNDS, COMPOSITIONS, PROCESS FOR PREPARATION, THEIR USES & APPLICATIONS - A compound which is the Michael addition reaction product of (A) a mono or polyacrylate of the formula R04-11-2013